Previous Article | Next Article 
Journal of Clinical Microbiology, December 2001, p. 4420-4425, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4420-4425.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Multidrug-Resistant Trichosporon asahii Infection
of Nongranulocytopenic Patients in Three Intensive Care
Units
Dana G.
Wolf,1
Rama
Falk,1
Moshe
Hacham,1
Bart
Theelen,2
Teun
Boekhout,2
Gloria
Scorzetti,3
Mervyn
Shapiro,1
Colin
Block,1
Ira F.
Salkin,4 and
Itzhack
Polacheck1,*
Department of Clinical Microbiology and
Infectious Diseases, The Hebrew University-Hadassah Medical Center,
Jerusalem, Israel1; CBS Yeast Division,
Utrecht, The Netherlands2; Rosenstiel
School of Marine and Atmospheric Sciences, University of Miami, Key
Biscayne, Florida3; and Wadsworth
Center, New York State Department of Health, Albany, New
York4
Received 8 December 2000/Returned for modification 18 March
2001/Accepted 30 September 2001
Trichosporon asahii (Trichosporon
beigelii) infections are rare but have been associated with a
wide spectrum of clinical manifestations, ranging from superficial
involvement in immunocompetent individuals to severe systemic disease
in immunocompromised patients. We report on the recent recovery of
T. asahii isolates with reduced susceptibility in vitro
to amphotericin B (AMB), flucytosine, and azoles from six
nongranulocytopenic patients who exhibited risk factors and who
developed either superficial infections (four individuals) or invasive
infections (two individuals) while in intensive care units. The latter
two patients responded clinically and microbiologically to AMB
treatment. All six isolates were closely related according to random
amplified polymorphic DNA studies and showed 71% similarity by
amplified fragment length polymorphism analysis, suggesting a common
nosocomial origin. We also review the literature pertaining to
T. asahii infections and discuss the salient
characteristics of this fungus and recent taxonomic proposals for the genus.
*
Corresponding author. Mailing address: Department of
Clinical Microbiology and Infectious Diseases, The Hebrew
University-Hadassah Medical Center, P.O. Box 12000, Jerusalem 91120, Israel. Phone: 972-2-677-6592. Fax: 972-2-676-9206. E-mail:
Itzhack.Polacheck{at}huji.ac.il.
Journal of Clinical Microbiology, December 2001, p. 4420-4425, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4420-4425.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Taj-Aldeen, S. J., Al-Ansari, N., El Shafei, S., Meis, J. F., Curfs-Breuker, I., Theelen, B., Boekhout, T.
(2009). Molecular Identification and Susceptibility of Trichosporon Species Isolated from Clinical Specimens in Qatar: Isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.. J. Clin. Microbiol.
47: 1791-1799
[Abstract]
[Full Text]
-
Chagas-Neto, T. C., Chaves, G. M., Melo, A. S. A., Colombo, A. L.
(2009). Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing. J. Clin. Microbiol.
47: 1074-1081
[Abstract]
[Full Text]
-
Rodriguez-Tudela, J. L., Diaz-Guerra, T. M., Mellado, E., Cano, V., Tapia, C., Perkins, A., Gomez-Lopez, A., Rodero, L., Cuenca-Estrella, M.
(2005). Susceptibility Patterns and Molecular Identification of Trichosporon Species. Antimicrob. Agents Chemother.
49: 4026-4034
[Abstract]
[Full Text]
-
Girmenia, C., Pagano, L., Martino, B., D'Antonio, D., Fanci, R., Specchia, G., Melillo, L., Buelli, M., Pizzarelli, G., Venditti, M., Martino, P., the GIMEMA Infection Program,
(2005). Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature. J. Clin. Microbiol.
43: 1818-1828
[Abstract]
[Full Text]
-
Serena, C., Pastor, F. J., Gilgado, F., Mayayo, E., Guarro, J.
(2005). Efficacy of Micafungin in Combination with Other Drugs in a Murine Model of Disseminated Trichosporonosis. Antimicrob. Agents Chemother.
49: 497-502
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J.
(2004). Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol.
42: 4419-4431
[Full Text]
-
Serena, C., Pastor, F. J., Ortoneda, M., Capilla, J., Nolard, N., Guarro, J.
(2004). In Vitro Antifungal Susceptibilities of Uncommon Basidiomycetous Yeasts. Antimicrob. Agents Chemother.
48: 2724-2726
[Abstract]
[Full Text]
-
Ramos, J. M., Cuenca-Estrella, M., Gutierrez, F., Elia, M., Rodriguez-Tudela, J. L.
(2004). Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism. J. Clin. Microbiol.
42: 2341-2344
[Abstract]
[Full Text]
-
Falk, R., Wolf, D. G., Shapiro, M., Polacheck, I.
(2003). Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole. J. Clin. Microbiol.
41: 911-911
[Full Text]